TY - JOUR
T1 - The cardio-oncology continuum
T2 - Bridging the gap between cancer and cardiovascular care
AU - Shaik, Tanveer
AU - Bhavsar, Jill
AU - Garg, Shreya
AU - Gupta, Vasu
AU - Kanagala, Sai Gautham
AU - Jain, Rohit
N1 - Publisher Copyright:
COPYRIGHT: 2024 The Author(s).
PY - 2024/1
Y1 - 2024/1
N2 - Cancer and cardiovascular disease are two of the leading causes of death worldwide. Although cancer has historically been viewed as a condition characterized by abnormal cell growth and proliferation, it is now recognized that cancer can lead to a variety of cardiovascular diseases. This is due to the direct impact of cancer on the heart and blood vessels, which can cause myocarditis, pericarditis, and vasculitis. Additionally, cancer patients frequently experience systemic effects such as oxidative stress, inflammation, and metabolic dysregulation, which can contribute to the development of cardiovascular risk factors such as hypertension, dyslipidemia, and insulin resistance. It is important to closely monitor patients with cancer, especially those undergoing chemotherapy or radiation therapy, for cardiovascular risk factors and promptly address them. This article aims to explore the clinical implications of the underlying mechanisms connecting cancer and cardiovascular diseases. Our analysis highlights the need for improved cooperation between oncologists and cardiologists, and specialized treatment for cancer survivors.
AB - Cancer and cardiovascular disease are two of the leading causes of death worldwide. Although cancer has historically been viewed as a condition characterized by abnormal cell growth and proliferation, it is now recognized that cancer can lead to a variety of cardiovascular diseases. This is due to the direct impact of cancer on the heart and blood vessels, which can cause myocarditis, pericarditis, and vasculitis. Additionally, cancer patients frequently experience systemic effects such as oxidative stress, inflammation, and metabolic dysregulation, which can contribute to the development of cardiovascular risk factors such as hypertension, dyslipidemia, and insulin resistance. It is important to closely monitor patients with cancer, especially those undergoing chemotherapy or radiation therapy, for cardiovascular risk factors and promptly address them. This article aims to explore the clinical implications of the underlying mechanisms connecting cancer and cardiovascular diseases. Our analysis highlights the need for improved cooperation between oncologists and cardiologists, and specialized treatment for cancer survivors.
UR - http://www.scopus.com/inward/record.url?scp=85181142349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85181142349&partnerID=8YFLogxK
U2 - 10.21542/gcsp.2024.9
DO - 10.21542/gcsp.2024.9
M3 - Review article
C2 - 38404658
AN - SCOPUS:85181142349
SN - 2305-7823
VL - 2024
JO - Global Cardiology Science and Practice
JF - Global Cardiology Science and Practice
IS - 1
ER -